Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tatsuaki Okamura"'
Publikováno v:
Drugs in R&D
Background and Objective Anaphylactic shock is a serious adverse drug reaction that can occur in response to contrast media used during coronary computed tomography angiography. The imaging quality of coronary computed tomography angiography is impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44453fc765c36dffb3ffc5204eca14a
https://doi.org/10.1007/s40268-021-00354-3
https://doi.org/10.1007/s40268-021-00354-3
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-6 (2019)
Scientific Reports
Scientific Reports
Beta-blockers have been reported to improve prognosis for various cancers, but the usefulness of perioperative administration remains unclear. To assess the efficacy of perioperative administration of landiolol hydrochloride, an intravenous beta-bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084e8dbe52287560a635f328cb103181
http://link.springer.com/article/10.1038/s41598-019-41520-7
http://link.springer.com/article/10.1038/s41598-019-41520-7
Autor:
Shigeto Oda, Tatsuaki Okamura, Motoi Odani, Tomohiro Harada, Yasuyuki Kakihana, Osamu Nishida, Eizo Watanabe
Publikováno v:
Shock (Augusta, Ga.)
Background: Sepsis often induces an immunosuppressive state, which is associated with high mortality rates. Immunostimulation may be beneficial for sepsis. We investigated the pharmacokinetics, pharmacodynamics, and safety of nivolumab, a human progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d629de704d7cfb443bcc46d777278d1
https://pubmed.ncbi.nlm.nih.gov/31513050
https://pubmed.ncbi.nlm.nih.gov/31513050
Autor:
Tatsuaki Okamura, Atsuhiro Sakamoto, Katsuhiro Fujino, Hirotsugu Atarashi, Takanori Ikeda, Masafumi Kitakaze, Ryozo Nagai, Koichiro Kinugawa, Wataru Shimizu, Takashi Daimon, Tetsuji Nagano, Takeshi Yamashita, Yoshihiko Seino, Hiroshi Inoue, Yasushi Imai, Takeshi Aiba, Masatsugu Hori
Publikováno v:
Advances in Therapy
Introduction Results from the multicenter trial (J-Land study) of landiolol versus digoxin in atrial fibrillation (AF) and atrial flutter (AFL) patients with left ventricular (LV) dysfunction revealed that landiolol was more effective for controlling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202e9ba33d7767a4c7a1a18d505e181f
http://europepmc.org/articles/PMC4003342
http://europepmc.org/articles/PMC4003342
Autor:
Eizo Watanabe, Osamu Nishida, Yasuyuki Kakihana, Motoi Odani, Tatsuaki Okamura, Tomohiro Harada, Shigeto Oda
Publikováno v:
Shock; Jun2020, Vol. 53 Issue 6, p686-694, 9p
Autor:
Ryozo, Nagai, Koichiro, Kinugawa, Hiroshi, Inoue, Hirotsugu, Atarashi, Yoshihiko, Seino, Takeshi, Yamashita, Wataru, Shimizu, Takeshi, Aiba, Masafumi, Kitakaze, Atsuhiro, Sakamoto, Takanori, Ikeda, Yasushi, Imai, Takashi, Daimon, Katsuhiro, Fujino, Tetsuji, Nagano, Tatsuaki, Okamura, Masatsugu, Hori, Tetsuji, Shinjyo
Publikováno v:
Circulation Journal. 77:908-916
Background: A rapid heart rate (HR) during atrial fibrillation (AF) and atrial flutter (AFL) in left ventricular (LV) dysfunction often impairs cardiac performance. The J-Land study was conducted to compare the efficacy and safety of landiolol, an ul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e02b4b576685245a44c2e8ae9e73f9
https://doi.org/10.1253/circj.cj-12-1618
https://doi.org/10.1253/circj.cj-12-1618